These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16631419)

  • 21. The 40 kDa carboxy-terminal domain of poly(ADP-ribose) polymerase-1 forms catalytically competent homo- and heterodimers in the absence of DNA.
    Mendoza-Alvarez H; Alvarez-Gonzalez R
    J Mol Biol; 2004 Feb; 336(1):105-14. PubMed ID: 14741207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations.
    Mendoza-Alvarez H; Chavez-Bueno S; Alvarez-Gonzalez R
    IUBMB Life; 2000 Aug; 50(2):145-9. PubMed ID: 11185961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.
    Pandya KG; Patel MR; Lau-Cam CA
    J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S16. PubMed ID: 20804590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel class of substituted spiro [quinazoline-2,1'-cyclohexane] derivatives as effective PPAR-1 inhibitors: molecular modeling, synthesis, cytotoxic and enzyme assay evaluation.
    Amin KM; Anwar MM; Syam YM; Khedr MA; Kamel MM; Kassem EM
    Acta Pol Pharm; 2013; 70(4):687-708. PubMed ID: 23923393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free energy calculation provides insight into the action mechanism of selective PARP-1 inhibitor.
    Cao R
    J Mol Model; 2016 Apr; 22(4):74. PubMed ID: 26969680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the enzymatic catalysis of poly(ADP-ribose) polymerase by dsDNA, polyamines, Mg2+, Ca2+, histones H1 and H3, and ATP.
    Kun E; Kirsten E; Mendeleyev J; Ordahl CP
    Biochemistry; 2004 Jan; 43(1):210-6. PubMed ID: 14705947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors].
    Yao HP; Zhu ZX; Ji M; Chen XG; Xu BL
    Yao Xue Xue Bao; 2014 Apr; 49(4):497-503. PubMed ID: 24974467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor.
    Wang B; Qian H; Yiu SM; Sun J; Zhu G
    Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose): PARadigms and PARadoxes.
    Bürkle A; Virág L
    Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of pyridazino[3,4,5-de]quinazolin-3(2H)-one as a new class of PARP-1 inhibitors.
    Wang J; Tan H; Sun Q; Ge Z; Wang X; Wang Y; Li R
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2340-4. PubMed ID: 25899312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational activation of poly(ADP-ribose) polymerase-1 upon DNA binding revealed by small-angle X-ray scattering.
    Mansoorabadi SO; Wu M; Tao Z; Gao P; Pingali SV; Guo L; Liu HW
    Biochemistry; 2014 Mar; 53(11):1779-88. PubMed ID: 24588584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3.
    Lindgren AE; Karlberg T; Thorsell AG; Hesse M; Spjut S; Ekblad T; Andersson CD; Pinto AF; Weigelt J; Hottiger MO; Linusson A; Elofsson M; Schüler H
    ACS Chem Biol; 2013 Aug; 8(8):1698-703. PubMed ID: 23742272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.
    D'Amours D; Desnoyers S; D'Silva I; Poirier GG
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):249-68. PubMed ID: 10455009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14).
    Schweiker SS; Tauber AL; Sherry ME; Levonis SM
    Mini Rev Med Chem; 2018; 18(19):1659-1669. PubMed ID: 30112992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The DNA binding and catalytic domains of poly(ADP-ribose) polymerase 1 cooperate in the regulation of chromatin structure and transcription.
    Wacker DA; Ruhl DD; Balagamwala EH; Hope KM; Zhang T; Kraus WL
    Mol Cell Biol; 2007 Nov; 27(21):7475-85. PubMed ID: 17785446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors.
    Salmas RE; Unlu A; Yurtsever M; Noskov SY; Durdagi S
    J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.
    Lehtiö L; Jemth AS; Collins R; Loseva O; Johansson A; Markova N; Hammarström M; Flores A; Holmberg-Schiavone L; Weigelt J; Helleday T; Schüler H; Karlberg T
    J Med Chem; 2009 May; 52(9):3108-11. PubMed ID: 19354255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,5-Diketopiperazines: A New Class of Poly(ADP-ribose)polymerase Inhibitors.
    Nilov DK; Yashina KI; Gushchina IV; Zakharenko AL; Sukhanova MV; Lavrik OI; Švedas VK
    Biochemistry (Mosc); 2018 Feb; 83(2):152-158. PubMed ID: 29618301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling.
    Ishida J; Yamamoto H; Kido Y; Kamijo K; Murano K; Miyake H; Ohkubo M; Kinoshita T; Warizaya M; Iwashita A; Mihara K; Matsuoka N; Hattori K
    Bioorg Med Chem; 2006 Mar; 14(5):1378-90. PubMed ID: 16288880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
    Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.